News

First Quantum Announces Upcoming Q3 2025 Financial Results

First Quantum Announces Upcoming Q3 2025 Financial Results

First Quantum Minerals Sets Expectations for Q3 2025 Results

TORONTO — First Quantum Minerals Ltd. (TSX: FM) is gearing up to unveil its financial and operational performance for the third quarter of 2025. Scheduled for a release after the Toronto Stock Exchange's closing bell on the 28th of October, the anticipation is palpable among investors and stakeholders eager for insights into the company’s progress.

Understanding the Upcoming Conference Call

The following day, on October 29, First Quantum will host a conference call and webcast aimed at discussing these critical results. This event is a fantastic opportunity for analysts and shareholders alike to gain a deeper understanding of the company’s position and future direction.

Details of the Call

Participants can join the call through different options: for those in North America, a toll-free number is available at 1-800-715-9871, while international attendees can reach out via +1-646-307-1963. It's important to note that those joining will need the Conference ID: 8111752 to participate effectively.

Webcast Access

For a more visual experience, the event will also be accessible via a webcast. This will allow stakeholders to follow along with the presentations in real time. Simply visit the First Quantum website for direct access to the event on the day of the call.

Post-Call Follow-Up

After the live session, a recording of the webcast will be made available on First Quantum’s official website. This is a great resource for those who cannot attend the live call, ensuring all stakeholders have the opportunity to stay informed.

Investor Relations Support

For further inquiries about the upcoming results or the call itself, investors can connect with the Investor Relations team. Bonita To, the Director of Investor Relations, can be reached at (416) 361-6400 for local calls, and for those utilizing the toll-free option, the number is 1 (888) 688-6577. Additionally, questions can also be directed through email at info@fqml.com.

Looking Ahead

As First Quantum continues to advance in its operational goals, the results from the third quarter will provide essential insights into its financial health and strategic positioning. Stakeholders will be keen to learn about the company’s initiatives and any new developments in their mining projects, which are critical in shaping future growth strategies.

Frequently Asked Questions

When will First Quantum release its Q3 2025 results?

The results are scheduled to be released after the market closes on October 28, 2025.

How can I join the conference call?

You can join by calling 1-800-715-9871 or +1-646-307-1963, using the Conference ID: 8111752.

Is there a way to access the webcast of the call?

Yes, the webcast can be accessed through links available on the First Quantum Minerals website.

Will there be a replay of the call?

Yes, a replay of the webcast will be made available on the company’s website after the call.

Who should I contact for more information?

For details, you can contact Bonita To, Director of Investor Relations at First Quantum, by phone or email.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Major Refinancing Deal in Multifamily Sector by Newmark Group

Updated Category News Views 168

Newmark Group Secures $690 Million for West Shore Portfolio Newmark Group, Inc. (NASDAQ: NMRK), a prominent name in commercial real estate advisory, has successfully arranged a substantial $690 million loan aimed at refinancing a diverse collection of 13 multifamily properties owned by West Shore. These properties are located in several states, including vibrant areas...

Continue Reading
MassageLuXe Expands Its Relaxation Services in Grand Rapids

Updated Category News Views 193

MassageLuXe Expands Its Relaxation Services in Grand Rapids MassageLuXe, a leading spa franchise known for its exceptional massage, facial, and waxing services, is gearing up to enhance wellness offerings in the Grand Rapids area. This strategic initiative marks the company's intent to further establish its footprint in Michigan's second-largest city, driven by the...

Continue Reading
Taylor Heise Joins Upper Deck: A Milestone in Women's Sports

Updated Category News Views 454

Taylor Heise Joins Upper Deck's Elite Team of Athletes Leading the charge in the realm of sports collectibles, Upper Deck recently announced an exciting partnership with Taylor Heise, a standout player in the Professional Women's Hockey League (PWHL). This collaboration highlights the growing prominence of women athletes in sports collectibles, specifically with Heise,...

Continue Reading
Eminent Gold Strengthens Team with Ivan Bebek's Expertise

Updated Category News Views 81

Eminent Gold Welcomes Ivan Bebek as Strategic Advisor Eminent Gold Corp. (TSXV: EMNT) (OTCQB: EMGDF) is making headlines with the recent appointment of Ivan Bebek as a Strategic Advisor for Corporate Development and Finance. This strategic move aims to bolster the company's efforts in identifying and advancing new gold discoveries in Nevada. Ivan Bebek: A Wealth of...

Continue Reading
B. Riley Financial Plans Hearing for Nasdaq Compliance Status

Updated Category News Views 167

Understanding B. Riley Financial's Nasdaq Situation B. Riley Financial, Inc. (Nasdaq: RILY) has announced a significant event regarding its listing status on the Nasdaq exchange. The company received a Staff Determination Letter from the Nasdaq Listing Qualifications Staff, pointing out non-compliance issues that date back to earlier notifications. These notifications...

Continue Reading